Table 2.
Clinicopathological summary of breast mucinous carcinoma.
| Older Group (≥65 y/o) |
Younger Group (<55 y/o) |
Fisher’s Exact Test (p-Value) | |
|---|---|---|---|
| Number of cases | 21 | 16 | |
| Age, mean ± SD (range) |
81.7 ± 6.81 (67–92) |
44.6 ± 8.63 (28–55) |
|
| T category (%) | 0.733 | ||
| T0 | 0 (0%) | 0 (0%) | |
| T1 | 7 (33.3%) | 8 (50.0%) | |
| T2 | 11 (52.4%) | 6 (37.5%) | |
| T3 | 3 (14.3%) | 2 (12.5%) | |
| T4 | 0 (0%) | 0 (0%) | |
| N stage | 1.000 | ||
| N0 | 18 (85.7%) | 14 (87.5%) | |
| N1 | 3 (14.3%) | 2 (12.5%) | |
| N2, N3 | 0 (0%) | 0 (0%) | |
| M category | |||
| M0 | 21 (100%) | 16 (100%) | |
| M1 | 0 (0%) | 0 (0%) | |
| TNM stage | 0.364 | ||
| Stage 0 | 0 (0%) | 0 (0%) | |
| Stage I | 7 (33.3%) | 8 (50%) | |
| Stage II | 13 (61.9%) | 6 (37.5%) | |
| Stage III | 1(4.8%) | 2 (12.5%) | |
| Stage IV | 0 (0%) | 0 (0%) | |
| Nuclear grade | 0.832 | ||
| Grade I | 4 (19.0%) | 4 (25.0%) | |
| Grade II | 10 (47.6%) | 8 (50.0%) | |
| Grade III | 7 (33.3%) | 4 (25.0%) |
SD, standard deviation.